Clinical management of chronic kidney disease-associated pruritus: current treatment options and future approaches
- PMID: 34987779
- PMCID: PMC8702820
- DOI: 10.1093/ckj/sfab167
Clinical management of chronic kidney disease-associated pruritus: current treatment options and future approaches
Abstract
Chronic kidney disease (CKD)-associated pruritus (CKD-aP) is an underdiagnosed yet severely distressing condition that impacts 60% of patients on dialysis and many nondialysis patients with Stages 3-5 CKD. However, despite its high prevalence, there are currently limited treatment options available for these patients and a lack of treatment guidelines for clinicians. In this manuscript, we reviewed the available literature in order to evaluate the current management and treatment options for CKD-aP, including dialysis management, topical treatments, gabapentinoids, opioids and alternative medicine. We also review the available data on CKD-aP treatments in development and propose new guidelines for managing patients with CKD-aP.
Keywords: CKD; CKD-aP; ESRD; itch; pruritus; uremic pruritus.
© The Author(s) 2021. Published by Oxford University Press on behalf of ERA.
References
-
- Yosipovitch G, Bernhard JD. Chronic pruritus. N Engl J Med 2013; 368: 1625–1634 - PubMed
-
- Zachariae R, Lei U, Hædersdal M et al. Itch severity and quality of life in patients with pruritus: preliminary validity of a Danish adaptation of the itch severity scale. Acta Derm Venerol 2012; 92: 508–514 - PubMed
-
- Pisoni RL, Wikstrom B, Elder SJ et al. Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2006; 21: 3495–3505 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
